BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 602346)

  • 1. Studies on lymphocytotoxicity in acute and chronic liver disease.
    Warnatz H; Gutmann W; Rösch W; Hommel G
    Z Immunitatsforsch Immunobiol; 1977 Dec; 153(5):435-49. PubMed ID: 602346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro studies on lymphocytotoxicity to synovial cells and Chang cells in rheumatoid arthritis patients and healthy controls.
    Warnatz H; Thommes M
    Z Rheumatol; 1979; 38(3-4):129-37. PubMed ID: 312567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological studies in patients with chronic active hepatitis. Cytotoxic activity of lymphocytes to autochthonous liver cells grown in tissue culture.
    Paronetto F; Vernace S
    Clin Exp Immunol; 1975 Jan; 19(1):99-104. PubMed ID: 1204242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity in acute and chronic hepatitis.
    Wands JR; Perrotto JL; Alpert E; Isselbacher KJ
    J Clin Invest; 1975 May; 55(5):921-9. PubMed ID: 1079030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and serum-induced lymphocytotoxicity against rabbit hepatocytes in chronic active hepatitis.
    Ortona L; Laghi V; Cauda R; Nervo P
    Boll Ist Sieroter Milan; 1981; 60(1):46-51. PubMed ID: 7272012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Direct and induced lymphocytotoxicity to rabbit hepatocytes in chronic active hepatitis].
    Laghi V; Cauda R; Nervo P
    Arch Sci Med (Torino); 1980; 137(4):575-7. PubMed ID: 7247672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis.
    Vergani GM; Vergani D; Jenkins PJ; Portmann B; Mowat AP; Eddleston AL; Williams R
    Clin Exp Immunol; 1979 Oct; 38(1):16-21. PubMed ID: 393438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro cell-mediated cytotoxicity for autologous liver cells in chronic non-A, non-B hepatitis.
    Mondelli M; Alberti A; Tremolada F; Williams R; Eddleston AL; Realdi G
    Clin Exp Immunol; 1986 Jan; 63(1):147-55. PubMed ID: 3082546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K-cell-mediated antibody-dependent cellular cytotoxicity in chronic active liver disease.
    Kawanishi H; MacDermott RP
    Gastroenterology; 1979 Jan; 76(1):151-8. PubMed ID: 361492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody dependent cellular cytotoxicity (ADCC) in acute hepatitis B and in chronic active hepatitis.
    Bortolotti F; Realdi G; Diodati G; Fattovich G
    Clin Exp Immunol; 1978 Aug; 33(2):211-6. PubMed ID: 719950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lymphocyte cytotoxicity in chronic active hepatitis.
    Kakumu S; Hara T; Gohji H; Sakamoto N
    Clin Exp Immunol; 1978 Jul; 33(1):71-8. PubMed ID: 709913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of cytotoxicity of lymphocyte populations in coloncarcinoma patients in comparison to normal controls using a new statistical method of evaluation.
    Warnatz H; Eder E; Lackner D; Hommel G
    Z Immunitatsforsch Immunobiol; 1977 Jul; 153(2):128-42. PubMed ID: 906620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytotoxins in acute and chronic hepatitis. Characterization and relationship to changes in circulating T lymphocytes.
    Dehoratius RJ; Henderson C; Strickland RG
    Clin Exp Immunol; 1976 Oct; 26(1):21-7. PubMed ID: 1087213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte cytotoxicity in alcoholic hepatitis.
    Kakumu S; Leevy CM
    Gastroenterology; 1977 Apr; 72(4 Pt 1):594-7. PubMed ID: 65306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte subpopulations at the site of "piecemeal" necrosis in end stage chronic liver diseases and rejecting liver allografts in cyclosporine-treated patients.
    Si L; Whiteside TL; Van Thiel DH; Rabin BS
    Lab Invest; 1984 Mar; 50(3):341-7. PubMed ID: 6366363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.
    Eggink HF; Houthoff HJ; Huitema S; Gips CH; Poppema S
    Clin Exp Immunol; 1982 Oct; 50(1):17-24. PubMed ID: 6983407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes.
    Mondelli M; Vergani GM; Alberti A; Vergani D; Portmann B; Eddleston AL; Williams R
    J Immunol; 1982 Dec; 129(6):2773-8. PubMed ID: 6982941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte cytotoxicity for isolated hepatocytes in acute viral and chronic active hepatitis.
    Cochrane M; Eddleston A; Williams R
    Minerva Med; 1978 Aug; 69(38):2543-8. PubMed ID: 714256
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphocyte populations in peripheral blood and in liver biopsy specimens from patients with acute and chronic hepatitis.
    Ferrau' O; Freni MA; Aiello A; Crino' M; Consolo F
    Hepatogastroenterology; 1981 Apr; 28(2):84-6. PubMed ID: 7216151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.